- The trend backdrop is active with a 5-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
HIVE
NASDAQ
Week ended 18 Sep 2026
Weekly Investor Report
HIVE Digital Technologies Ltd · Financial Services · Capital Markets
Latest close
3.41 USD
12.5%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 16.7% above the Trend Line and sits at 27.5% of its 52-week range. The latest completed week returned 12.5%, after a 12.5% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is bullish with 51/100 conviction, while the latest news-sentiment score is 47/100. Near-term considerations: volume confirmation is below normal; earnings are due in 50d.
Setup score
37
out of 100
Latest Close
3.41 USD
18 Sep 2026
1W Return
12.5%
latest completed week
4W Return
12.5%
short-term follow-through
12W Return
-15.4%
quarterly tape
Trend Breadth
48.1%
25 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 37.80% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
12.5%
Latest completed week; four-week move 12.5%.
Indicator stack
44/36
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 37.80%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Bullish
51/100 conviction; expected move 0.0%.
News sentiment
47/100
43 relevant articles in the latest sentiment read.
Event risk
50d
Next report is scheduled for 13 Nov 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 16.7% above the Trend Line and sits at 27.5% of its 52-week range. The latest completed week returned 12.5%, after a 12.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
21 Aug
28 Aug
4 Sep
11 Sep
18 Sep
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2212-week average 0.47
12-week confirmation
Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.22Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 12.5% over four weeks, -15.4% over 12 weeks, and -10.0% over one year. The current trend has remained active for 5 consecutive weeks.
Performance by holding period
Active trend streak5 weeks
Active weeks in one year25
Trend breadth48.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.64Latest activity-pressure read.
Pressure change-36.5%Four-week change in activity pressure.
Leadership-4.66Latest relative-leadership reading.
RS change71.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.
Factor week 18 Sep 2026
Financial statements through 30 Jun 2026
Field coverage 91%
Model confidence 91%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength5/100Blend of value, momentum, and quality. Underlying universe rank 96; rank 1 is best.
Value19/100Relative valuation strength. Underlying universe rank 82; rank 1 is best.
Quality4/100Profitability and accounting quality. Underlying universe rank 97; rank 1 is best.
Momentum28/100Medium-term price momentum. Underlying universe rank 73; rank 1 is best.
Growth90/100Revenue and earnings growth. Underlying universe rank 11; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 2.8x Market value relative to trailing revenue.
- EV / EBITDA
- 495.2x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -11.3% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- -32.5% Gross profit retained from each unit of revenue.
- Operating margin
- -60.7% Operating profit retained from revenue.
- Free-cash-flow margin
- -37.8% Free cash flow generated from revenue.
- Return on invested capital
- -25.5% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 156.0% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -16.9% Net share repurchases relative to market value.
- Shareholder yield
- -16.9% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 74.6x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningBullish
HIVE shows bullish options pressure with a 51/100 conviction score, put-call volume ratio of 0.30, expected move of n/a, and Sharemaestro trend signal active.
Conviction51/100
Expected move%
Put/call volume0.30
Insider activity-
No recent insider transactions are stored for this company.
News sentiment47/100
Weighted news tone is neutral across 43 relevant articles.
11 positive · 22 neutral · 10 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings50dNext report is scheduled for 13 Nov 2026; event risk rises as the date approaches.
Options expected move%Nearest-chain priced movement where available.
52-week drawdown-56.5%Distance below the 52-week high.
13-week volatility9.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
27 Mar
24 Apr
22 May
19 Jun
17 Jul
14 Aug
18 Sep
Weeks higher14 of 2612 weeks finished lower.
Best week+51.3%Week of 22 May.
Worst week-19.6%Week of 3 Jul.
Latest week+12.5%Week of 18 Sep.
Shape of recent returns
Strong gains10
Modest gains4
Flat weeks0
Modest losses3
Sharp losses9
Recent vol9.7%13-week weekly-return volatility.
Base vol14.8%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew13.0% / -8.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Financial Services
4-week rank- / 100
Group average-2.3%
Trend breadth81.0%
Trend81.0%active weekly trend signals
MD64.0%positive activity pressure
RS40.0%positive relative leadership
Four-week leaders
IndustryUS Capital Markets
4-week rank25 / 84
Group average5.0%
Trend breadth36.9%
Trend36.9%active weekly trend signals
MD54.8%positive activity pressure
RS19.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape34/100
Trend, activity pressure, participation, and risk combine to a 34/100 tape read.
Indicator analysis42/100Latest 12-week confirmation: trend 11/12, activity pressure 4/12, relative leadership 0/12.
Activity pressure 0.22; No reversal markers Next-Week ExpectancyNegative 37.80%Next-week expectancy is negative with a 37.80% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors12/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 93; Small Cap Core rank 92 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options61/100Call activity leads. Options balance does not yet confirm the saved weekly stock trend.
2026-09-23 · Use with limits · Priced move Unavailable Sentiment47/100Weighted news tone is neutral across 43 relevant articles.
HIVE's Stock Plummets On Q4 Earnings Miss — Chairman Says Share Price Volatility Is A 'Non-Event' Insiders50/100No recent insider transaction evidence is stored.
Earnings50dNext report is scheduled for 13 Nov 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 18 Sep 2026 | 3.41 USD | 12.5% | 2.92 USD | 3.05 USD | -0.64 | -4.66 | 74.5M | On |
| 11 Sep 2026 | 3.03 USD | -2.6% | 2.88 USD | 3.05 USD | -0.62 | -15.04 | 45.7M | On |
| 4 Sep 2026 | 3.11 USD | 12.1% | 2.85 USD | 3.05 USD | -0.60 | -14.05 | 73.6M | On |
| 28 Aug 2026 | 2.78 USD | -8.4% | 2.82 USD | 3.05 USD | -0.56 | -23.12 | 91.1M | On |
| 21 Aug 2026 | 3.03 USD | 12.6% | 2.82 USD | 3.06 USD | -0.47 | -16.13 | 219.2M | On |
| 14 Aug 2026 | 2.69 USD | -5.3% | 2.83 USD | 3.06 USD | -0.50 | -27.39 | 109.6M | Off |
| 7 Aug 2026 | 2.84 USD | 0.4% | 2.86 USD | 3.06 USD | -0.40 | -22.54 | 69.8M | On |
| 31 Jul 2026 | 2.83 USD | -4.4% | 2.87 USD | 3.08 USD | -0.19 | -18.78 | 90.8M | On |
| 24 Jul 2026 | 2.96 USD | 3.9% | 2.86 USD | 3.09 USD | 0.02 | -14.44 | 76.3M | On |
| 17 Jul 2026 | 2.85 USD | -14.9% | 2.86 USD | 3.10 USD | 0.48 | -18.84 | 71.6M | On |
| 10 Jul 2026 | 3.35 USD | 3.4% | 2.85 USD | 3.12 USD | 0.84 | -8.54 | 78.2M | On |
| 3 Jul 2026 | 3.24 USD | -19.6% | 2.84 USD | 3.14 USD | 1.05 | -9.78 | 100.1M | On |
| 26 Jun 2026 | 4.03 USD | -5.4% | 2.84 USD | 3.15 USD | 1.32 | 13.35 | 256.6M | On |
| 19 Jun 2026 | 4.26 USD | 14.2% | 2.82 USD | 3.15 USD | 1.33 | 15.49 | 117.3M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.